Madopar

Known as: madopa, modopar 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
We used positron emission tomography (PET) and the 18-flourodeoxyglucose tracer to study cerebral effects of complementary… (More)
Is this relevant?
2008
2008
  • Xiao-ming Ren
  • Journal of traditional Chinese medicine = Chung i…
  • 2008
OBJECTIVE To search for an effective therapy for treating motor disorder due to Parkinson's disease (PD). METHODS Fifty cases… (More)
Is this relevant?
1996
1996
In this Danish-Norwegian randomized double-blind parallel-group multicentre study, we compared the therapeutic response of slow… (More)
Is this relevant?
1991
1991
In a randomised, double-blind cross-over study, objective measures were used to compare the effect of a single oral dose of a… (More)
Is this relevant?
1989
1989
Urinary salsolinol output had been shown to be lower in Parkinsonian patients than in controls and to increase largely after L… (More)
Is this relevant?
1988
1988
In an open-label study, we substituted conventional levodopa plus benserazide: 100/25 (Madopar) with a controlled-release form… (More)
Is this relevant?
1987
1987
Eight healthy male and fasted volunteers received alternatively either one HBS capsule of Madopar 125 or two HBS capsules of… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
In an open, uncontrolled study the longterm (9 years) effect of treatment with Madopar® alone (n=377) or in combination with l… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
Is this relevant?
1977
1977
In a clinical trial the effect of L-deprenil, a selective irreversible inhibitor of monoamine oxidase (M.A.O.) "type B" in… (More)
Is this relevant?
Highly Cited
1975
Highly Cited
1975
The potentiation of the ami akinetic effect after L-Dopa treatment by an inhibitor of monoamine oxidase (MAO) “B”, Deprenil, has… (More)
  • figure 1
  • table 3
  • table 4
  • figure 2
  • figure 2
Is this relevant?